Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges. - Wikidata - wikimedia - TriplyDB

Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.

Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.

http://www.wikidata.org/entity/Q37866289

about

The Need for Pediatric Formulations to Treat Children with HIV Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study.Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.Pharmacotherapy of pediatric HIV infection Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO.Design, evaluation, and dissemination of a plastic syringe clip to improve dosing accuracy of liquid medications.Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV

P2860

Q26740369-E54D8125-4052-48EA-B84F-5A4A2110E1D9 Q33413634-C56CD408-EBB7-4504-B7C2-3C38813664EE Q33611392-5A540663-A3AF-48A4-9533-90BC35C3D388 Q35488671-AD64FB5C-15CD-46B1-A85F-CEE6F8071CF2 Q35942341-C3BE3F65-36F2-45FC-9059-0E1DB32F9EBB Q36301325-E86E88E5-AF4F-4832-A1DC-617DC0B6E42A Q37205614-6CD1E370-7240-4DD5-BE75-35545B848624 Q40377157-F20A6B71-BE28-4522-B9F8-F1621B589317 Q40722214-69392F79-96DE-420C-B248-8EF184A4380A Q45048524-246D8153-202C-4978-9053-9E55D47974E6 Q56910418-4D73DA32-58D9-4A1F-853A-34138C43186E

P2860

Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.

http://www.wikidata.org/entity/Q37866289

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiretroviral drugs in pediat ...... etic and practical challenges.

@en

Antiretroviral drugs in pediat ...... etic and practical challenges.

@nl

type

label

Antiretroviral drugs in pediat ...... etic and practical challenges.

@en

Antiretroviral drugs in pediat ...... etic and practical challenges.

@nl

prefLabel

Antiretroviral drugs in pediat ...... etic and practical challenges.

@en

Antiretroviral drugs in pediat ...... etic and practical challenges.

@nl

P1433

Q37866289-DF96662D-8F9D-4AE5-8A19-64314CFFCEE4

P1476

Q37866289-107E8F15-E89E-4443-9842-14A2CF07C602

P2093

Q37866289-732FA63B-DC29-472B-AA9F-EAC2EE670DF9

P2860

Q37866289-007D030C-992F-4BCF-9D30-141990455DD6

Q37866289-08681140-B583-4708-93F8-F7394C2D8EC0

Q37866289-0924A1C0-EBBD-4802-8BE3-07BE5DD016E0

Q37866289-0B56FC2E-1BE2-44EF-AA30-5B17661EC0B0

Q37866289-0DD061A3-8B43-4BCC-9C0A-C935EC9DD675

Q37866289-13DFF1B6-13D0-4872-B42D-B6D5FF32F065

Q37866289-1570BAC0-BC72-42A2-B8A7-25C3243EB418

Q37866289-1831F276-3986-41E7-92A8-5D34E7A19849

Q37866289-184A8D54-BDA5-419C-B3FC-2B897F4AE017

Q37866289-1B1398DC-1530-4D4D-95E4-AE19FACB0DBB

P2888

Q37866289-AA5D0377-3320-432F-8444-34243521C346

P304

Q37866289-9E2DD8FF-8C29-4823-9266-9DB727D9EB87

P31

Q37866289-9ED3F3D5-ED29-44D2-B8FB-3E4C096C66DE

P356

Q37866289-EC67BD3C-4FB7-44AC-8459-993D0FDF304E

P433

Q37866289-5A34BB74-103F-4AFB-84A2-459C39E5CC58

P478

Q37866289-78D1023A-7C02-4948-A6F9-19212632C02B

P50

Q37866289-0FA8C4E6-C273-49ED-95D4-A39C8223FFA2

P577

Q37866289-BB51DA82-38DF-4EA9-866F-49187F9BED06

P6179

Q37866289-637134CC-F83F-450B-9AC1-85996CC0BE93

P698

Q37866289-554735F8-0F7D-421A-B30C-A48974E1716E

P921

Q37866289-B7526A6E-9C27-40F0-B831-1B3BE477C8F3

Q37866289-C4B263DD-2D4C-4D9A-BD72-BEF1F47AA431

P356

11587300-000000000-00000

P1433

Pediatric Drugs

P1476

Antiretroviral drugs in pediat ...... etic and practical challenges.

@en

P2093

B Ryan Phelps

http://www.w3.org/2001/XMLSchema#string

P2860

Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all

Weight variability of pharmacist-dispensed split tablets

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.

Efavirenz in the therapy of HIV infection.

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial

Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children

P2888

11587300-000000000-00000

P304

175-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11587300-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Natella Rakhmanina

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032780230

http://www.w3.org/2001/XMLSchema#string

P698

21500872

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug